Circadian alignment and sleep-onset support

Melatonin

Meta-analyses support modest sleep-onset latency reduction and circadian realignment benefits, with outcomes sensitive to dose and timing.

Evidence Level A

Evidence and Risk Labels

Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.

See full scoring guide

Clinical Snapshot

Effect Size
Reliable sleep-onset benefit with modest total-sleep-time gains
Safety
Moderate Risk

Dose timing is critical and overuse may worsen morning grogginess.

Research Dosing

This reflects common ranges and protocols used in published studies, not personal medical advice.

Typical Daily Dose
0.3-3 mg
Timing
30-90 minutes before target bedtime
Protocol Duration in Studies
Short cycles or targeted periods, then reassess

Lower doses often achieve circadian goals with fewer next-day side effects.

Best Fit Profiles

  • circadian reset protocols
  • travel-related sleep disruption

Source Links